Skip to Content

1,348 Results Found

  • Review
  • Open Access
38 Citations
10,902 Views
26 Pages

12 October 2011

Uptake transporters (e.g., members of the SLC superfamily of solute carriers) and export proteins (e.g., members of the ABC transporter superfamily) are important determinants for the pharmacokinetics of drugs. Alterations of drug transport due to co...

  • Review
  • Open Access
24 Citations
9,001 Views
16 Pages

Nephroprotective Properties of Antidiabetic Drugs

  • Christian Gerdes,
  • Nicolle Müller,
  • Gunter Wolf and
  • Martin Busch

10 May 2023

Chronic kidney disease (CKD) is associated with increased morbidity and mortality, especially from cardiovascular (CV) causes, and especially in people with diabetes mellitus (DM). Already the presence of DM increases CV risk and potentiates the risk...

(This article belongs to the Special Issue Diabetic Kidney Disease: Epidemiology, Risk Factors for Disease Progression and Cardiovascular Complications, Novel Diagnostics and Treatments)
  • Review
  • Open Access
16 Citations
6,712 Views
17 Pages

Antidiabetic Drugs in Breast Cancer Patients

  • Wojciech Garczorz,
  • Agnieszka Kosowska and
  • Tomasz Francuz

10 January 2024

Diabetes is one of the leading chronic conditions worldwide, and breast cancer is the most prevalent cancer in women worldwide. The linkage between diabetes and its ability to increase the risk of breast cancer should always be analyzed in patients....

(This article belongs to the Special Issue Breast Cancer: Prevention and Treatment)
  • Article
  • Open Access
2 Citations
2,447 Views
10 Pages

Genetic Variation in Targets of Antidiabetic Drugs and Amyotrophic Lateral Sclerosis Risk

  • Mengxia Wan,
  • Linjing Zhang,
  • Junyan Huo,
  • Yu Fu and ,
  • Tao Huang and
  • Dongsheng Fan
  • + 1 author+ 0 author

29 November 2024

Background: Previous studies have suggested that antidiabetic drug use may be associated with amyotrophic lateral sclerosis. However, these studies are limited by many confounding and reverse causality biases. We aimed to determine whether antidiabet...

(This article belongs to the Section Nanomedicine and Nanobiology)
  • Review
  • Open Access
16 Citations
5,354 Views
13 Pages

Dementia dramatically affects the activities of daily living and quality of life; thus, many therapeutic approaches for overcoming dementia have been developed. However, an effective treatment regimen is yet to be developed. As diabetes is a well-kno...

(This article belongs to the Special Issue Diabetes and Dementia)
  • Review
  • Open Access
127 Citations
10,500 Views
12 Pages

Effects of Antidiabetic Drugs on Gut Microbiota Composition

  • Sophie A. Montandon and
  • François R. Jornayvaz

30 September 2017

Gut microbiota forms a catalog of about 1000 bacterial species; which mainly belong to the Firmicutes and Bacteroidetes phyla. Microbial genes are essential for key metabolic processes; such as the biosynthesis of short-chain fatty acids (SCFA); amin...

(This article belongs to the Special Issue Diabetes, Obesity and the Gut Microbiome)
  • Article
  • Open Access
4 Citations
3,552 Views
14 Pages

Repurposing the Antidiabetic Drugs Glyburide, Gliquidone, and Glipizide in Combination with Benznidazole for Trypanosoma cruzi Infection

  • Citlali Vázquez,
  • Rusely Encalada,
  • Isabel Jiménez-Galicia,
  • Rogelio Gómez-Escobedo and ,
  • Gildardo Rivera,
  • Benjamín Nogueda-Torres and
  • Emma Saavedra
  • + 2 authors+ 0 author

27 December 2024

Infection with the protozoan parasite Trypanosoma cruzi causes human Chagas disease. Benznidazole (BNZ) and nifurtimox are the current drugs for the treatment; however, they induce severe adverse side effects in patients; therefore, there is a need t...

(This article belongs to the Special Issue Drug Discovery and Development for Parasitic Diseases)
  • Review
  • Open Access
1 Citations
2,522 Views
20 Pages

9 February 2026

Background/Objectives: The efficacy of antidiabetic drugs is determined by intracellular target exposure rather than solely by plasma concentrations. This review synthesizes current evidence regarding subcellular drug distribution and its clinical si...

  • Review
  • Open Access
21 Citations
13,262 Views
40 Pages

Dietary Modulation of CYP3A4 and Its Impact on Statins and Antidiabetic Drugs: A Narrative Review

  • Manuel Hernández-Lorca,
  • Isabel M. Timón,
  • Pura Ballester,
  • Paula Henarejos-Escudero and ,
  • Ana María García-Muñoz,
  • Desirée Victoria-Montesinos and
  • Pablo Barcina-Pérez
  • + 2 authors+ 0 author

9 September 2025

Cytochrome P450 3A4 (CYP3A4) is a key enzyme involved in the metabolism of nearly half of all clinically used drugs, including widely prescribed statins and antidiabetic agents. Dietary constituents can modulate CYP3A4 expression and activity through...

(This article belongs to the Special Issue The Application of Pharmacogenetics in Toxicity Prevention and Drug Effect Improvement)
  • Article
  • Open Access
7 Citations
3,906 Views
21 Pages

Real World Use of Antidiabetic Drugs in the Years 2011–2017: A Population-Based Study from Southern Italy

  • Ylenia Ingrasciotta,
  • Maria Paola Bertuccio,
  • Salvatore Crisafulli,
  • Valentina Ientile and ,
  • Marco Muscianisi,
  • Luca L’Abbate,
  • Maurizio Pastorello,
  • Vincenzo Provenzano,
  • Alessandro Scorsone and
  • Gianluca Trifirò
  • + 6 authors+ 1 author

Diabetes mellitus is a metabolic disease characterized by chronic hyperglycemia. The availability of new antidiabetic drugs (ADs) has led to complex treatment patterns and to changes in the patterns of specific drug utilization. The aim of this popul...

(This article belongs to the Special Issue Real-World Evidence in Clinical Epidemiology and Public Health)
  • Article
  • Open Access
14 Citations
4,669 Views
17 Pages

12 January 2023

Ethanolic extract obtained from Annona cherimola Miller (EEAc) and the flavonoid rutin (Rut) were evaluated in this study to determine their antihyperglycemic content, % HbA1c reduction, and antihyperlipidemic activities. Both treatments were evaluat...

(This article belongs to the Special Issue Pharmacological Activities of Flavonoids and Its Analogues)
  • Systematic Review
  • Open Access
25 Citations
5,064 Views
20 Pages

Novel Antidiabetic Drugs and the Risk of Diabetic Retinopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  • Artur Małyszczak,
  • Joanna Przeździecka-Dołyk,
  • Urszula Szydełko-Paśko and
  • Marta Misiuk-Hojło

20 March 2024

Background: The aim of this study is to compare the effect of sodium–glucose cotransporter-2 inhibitors (SGLT-2i), glucagon-like peptide-1 receptor agonists (GLP-1RA), and dipeptidyl peptidase-4 inhibitors (DPP-4i) on the risk of diabetic retin...

(This article belongs to the Section Ophthalmology)
  • Systematic Review
  • Open Access
83 Citations
17,310 Views
23 Pages

Adherence to Oral Antidiabetic Drugs in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis

  • Eugenia Piragine,
  • Davide Petri,
  • Alma Martelli,
  • Vincenzo Calderone and
  • Ersilia Lucenteforte

2 March 2023

Poor adherence to oral antidiabetic drugs (OADs) in patients with type 2 diabetes (T2D) can lead to therapy failure and risk of complications. The aim of this study was to produce an adherence proportion to OADs and estimate the association between g...

(This article belongs to the Section Pharmacology)
  • Review
  • Open Access
2 Citations
9,993 Views
50 Pages

Drug–Drug and Drug–Disease Interactions Across Antidiabetic Drug Classes: A Narrative Review and Practical Recommendations

  • Cristina-Elena Zbârcea,
  • Cristian-Daniel Marineci,
  • Andrei Văleanu,
  • Cornel Chiriță and
  • Oana-Cristina Șeremet

Background: The pharmacological management of type 2 diabetes mellitus has become increasingly complex due to expanding therapeutic options and the high prevalence of multimorbidity in affected patients. As a result, the risk of drug–drug and d...

  • Article
  • Open Access
5 Citations
4,891 Views
17 Pages

Antidiabetic Drug Prescription Pattern in Hospitalized Older Patients with Diabetes

  • Ilaria Ardoino,
  • Sara Mandelli,
  • Marta Baviera,
  • Raffaella Rossio and ,
  • Alessandro Nobili,
  • Pier Mannuccio Mannucci,
  • Carlotta Franchi and
  • on behalf of REPOSI Investigator
  • + 3 authors+ 0 author

Objective: To describe the prescription pattern of antidiabetic and cardiovascular drugs in a cohort of hospitalized older patients with diabetes. Methods: Patients with diabetes aged 65 years or older hospitalized in internal medicine and/or geriatr...

(This article belongs to the Collection Health Care and Diabetes)
  • Review
  • Open Access
62 Citations
8,264 Views
17 Pages

Antidiabetic Drugs in the Treatment of Alzheimer’s Disease

  • Michalis Michailidis,
  • Despina A. Tata,
  • Despina Moraitou,
  • Dimitrios Kavvadas and ,
  • Sofia Karachrysafi,
  • Theodora Papamitsou,
  • Patroklos Vareltzis and
  • Vasileios Papaliagkas
  • + 3 authors+ 0 author

The public health burden of type 2 diabetes mellitus and Alzheimer’s disease is steadily increasing worldwide, especially in the population of older adults. Epidemiological and clinical studies suggest a possible shared pathophysiology between...

(This article belongs to the Special Issue Diabetes and Dementia)
  • Review
  • Open Access
45 Citations
9,694 Views
19 Pages

Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?

  • Matteo Tacelli,
  • Ciro Celsa,
  • Bianca Magro,
  • Aurora Giannetti and ,
  • Grazia Pennisi,
  • Federica Spatola and
  • Salvatore Petta
  • + 2 authors+ 0 author

8 November 2018

Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of chronic liver disease in Western countries, accounting for 20–30% of general population and reaching a prevalence of 55% in patients with type 2 diabetes mellitus (T2DM). Ins...

  • Review
  • Open Access
16 Citations
5,638 Views
18 Pages

Drug Delivery Strategies for Enhancing the Therapeutic Efficacy of Toxin-Derived Anti-Diabetic Peptides

  • Reeju Amatya,
  • Taehoon Park,
  • Seungmi Hwang,
  • JaeWook Yang and ,
  • Yoonjin Lee,
  • Heesun Cheong,
  • Cheol Moon,
  • Hyun Duck Kwak,
  • Kyoung Ah Min and
  • Meong Cheol Shin
  • + 5 authors+ 0 author

10 May 2020

Toxin peptides derived from the skin secretions of amphibians possess unique hypoglycemic activities. Many of these peptides share cationic and amphipathic structural similarities and appear to possess cell-penetrating abilities. The mechanism of the...

(This article belongs to the Section Animal Venoms)
  • Article
  • Open Access
9 Citations
2,639 Views
15 Pages

12 October 2024

Due to the increased prevalence of diabetes, the consumption of anti-diabetic drugs for its treatment has likewise increased. Metformin is an anti-diabetic drug that is commonly prescribed for patients with type 2 diabetes and has been frequently det...

(This article belongs to the Special Issue Analytical Chemistry in Europe: Towards Sustainability and Quality of Life, 2nd Edition)
  • Review
  • Open Access
11 Citations
4,529 Views
20 Pages

Electrochemical Assays for the Determination of Antidiabetic Drugs—A Review

  • Katarzyna Fendrych,
  • Anna Górska-Ratusznik and
  • Joanna Smajdor

20 December 2023

This article presents the current state of knowledge regarding electrochemical methods for determining the active substances within drugs that are used in the treatment of type 1 and type 2 diabetes. Electrochemical methods of analysis, due to their...

(This article belongs to the Special Issue Micro and Nanosensors: Fabrication, Applications and Performance Enhancements)
  • Review
  • Open Access
33 Citations
6,646 Views
26 Pages

Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials

  • Keren Esther Kristina Mantik,
  • Sujin Kim,
  • Bonsang Gu,
  • Sohee Moon and ,
  • Hyo-Bum Kwak,
  • Dong-Ho Park and
  • Ju-Hee Kang
  • + 2 authors+ 0 author

Insulin resistance as a hallmark of type 2 DM (T2DM) plays a role in dementia by promoting pathological lesions or enhancing the vulnerability of the brain. Numerous studies related to insulin/insulin-like growth factor 1 (IGF-1) signaling are linked...

(This article belongs to the Special Issue New Targets and Approaches for the Treatment of Alzheimer's Disease and Related Disorders)
  • Review
  • Open Access
4 Citations
1,870 Views
22 Pages

Cardiometabolic Comorbidities in COPD: Focus on Diabetes, GLP-1 Receptor Agonists, SGLT-2 Inhibitors and Antidiabetic Drugs

  • Maria Kallieri,
  • Georgios Hillas,
  • Stelios Loukides,
  • Konstantinos Kostikas and
  • Athena Gogali

9 March 2026

Background/Objectives: The coexistence of chronic obstructive pulmonary disease (COPD) and type 2 diabetes mellitus (T2D) poses significant clinical challenges due to overlapping mechanisms of systemic inflammation, oxidative stress, hypoxia, and met...

(This article belongs to the Special Issue Advances in the Personalized Management of Chronic Obstructive Pulmonary Disease (COPD))
  • Systematic Review
  • Open Access
13 Citations
3,740 Views
15 Pages

Non-Insulin Novel Antidiabetic Drugs Mechanisms in the Pathogenesis of COVID-19

  • Teodor Salmen,
  • Valeria-Anca Pietroșel,
  • Bianca-Margareta Mihai,
  • Ioana Cristina Bica and ,
  • Claudiu Teodorescu,
  • Horia Păunescu,
  • Oana Andreia Coman,
  • Doina-Andrada Mihai and
  • Anca Pantea Stoian
  • + 4 authors+ 0 author

The present study aimed to analyse the published data and to realize an update about the use and pathogenesis of the novel antidiabetic drugs, respectively, dipeptidyl peptidase-4 inhibitors (DPP-4i), glucagon-like peptide-1 receptor agonists (GLP-1...

(This article belongs to the Section Endocrinology and Metabolism Research)
  • Review
  • Open Access
86 Citations
9,753 Views
22 Pages

Links between Metabolic Syndrome and Hypertension: The Relationship with the Current Antidiabetic Drugs

  • Silviu Stanciu,
  • Emilia Rusu,
  • Daniela Miricescu,
  • Ana Cristina Radu and ,
  • Bianca Axinia,
  • Ana Maria Vrabie,
  • Ruxandra Ionescu,
  • Mariana Jinga and
  • Carmen Adella Sirbu
  • + 4 authors+ 0 author

5 January 2023

Hypertension poses a significant burden in the general population, being responsible for increasing cardiovascular morbidity and mortality, leading to adverse outcomes. Moreover, the association of hypertension with dyslipidaemia, obesity, and insuli...

(This article belongs to the Special Issue Altered Metabolism Associated with Hypertension—a New Option for Drug Therapy?)
  • Article
  • Open Access
25 Citations
3,981 Views
17 Pages

The discovery of new oral antidiabetic drugs remains a priority in medicine. This research aimed to evaluate the activity of the flavonoid baicalein and its natural glucuronide baicalin, compared to the antidiabetic drug metformin, as potential antig...

(This article belongs to the Special Issue Recent Advances in Natural Product Drugs)
  • Review
  • Open Access
21 Citations
13,139 Views
19 Pages

Type 2 diabetes (T2DM) is a chronic metabolic disease with a steadily increasing prevalence worldwide. Diabetes affects the function of many organs, including the skin. Pharmacotherapy for T2DM is mainly based on oral hypoglycemic drugs. The therapeu...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
8 Citations
3,516 Views
15 Pages

Single versus Double Coffee-Ring Effect Patterns in Thin-Layer Chromatography Coupled with Surface-Enhanced Raman Spectroscopic Analysis of Anti-Diabetic Drugs Adulterated in Herbal Products

  • Dao Thi Cam Minh,
  • Le Thi Bao Tram,
  • Nguyen Hai Phong,
  • Hoang Thi Lan Huong and ,
  • Le Van Vu,
  • Le Anh Thi,
  • Nguyen Thi Kieu Anh and
  • Pham Thi Thanh Ha
  • + 3 authors+ 0 author

18 July 2023

In thin-layer chromatography coupled with surface-enhanced Raman spectroscopy (TLC-SERS), the coffee ring effect (CRE) describes the formation of a ring-shape spot (blank in the middle and darker on the edge) caused by the aggregation of silver nanop...

(This article belongs to the Special Issue The Role of Raman Spectroscopy in Analytical Sciences)
  • Article
  • Open Access
24 Citations
8,176 Views
19 Pages

8 October 2023

The current research is aimed at investigating the relationship between the formulation components and conditions in the case of a binary drug delivery system, where antidiabetic drugs are co-formulated into polymeric micelles embedded in sodium algi...

(This article belongs to the Special Issue Polymers in Biomedical Applications)
  • Review
  • Open Access
30 Citations
8,566 Views
24 Pages

Systematic Review of Efficacy and Safety of Newer Antidiabetic Drugs Approved from 2013 to 2017 in Controlling HbA1c in Diabetes Patients

  • Sivanandy Palanisamy,
  • Emily Lau Hie Yien,
  • Ling Wen Shi,
  • Low Yi Si and ,
  • See Hui Qi,
  • Laura Soon Cheau Ling,
  • Teng Wai Lun and
  • Yap Nee Chen
  • + 3 authors+ 0 author

Type 2 Diabetes Mellitus (T2DM) is the most common form of diabetes mellitus and accounts for about 95% of all diabetes cases. Many newer oral as well as parenteral antidiabetic drugs have been introduced in to the market in recent years to control h...

(This article belongs to the Special Issue Improving Medication Safety: Role of Providers, Patients and Technology)
  • Review
  • Open Access
7 Citations
3,153 Views
19 Pages

The Reasons for the Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects—A Family Doctor Perspective

  • Tomislav Kurevija,
  • Dunja Šojat,
  • Zvonimir Bosnić,
  • Blerim Mujaj and ,
  • Silvija Canecki Varžić and
  • Ljiljana Majnarić Trtica
  • + 1 author+ 0 author

12 March 2024

Chronic diseases, such as type 2 diabetes (T2D), are difficult to manage because they demand continuous therapeutic review and monitoring. Beyond achieving the target HbA1c, new guidelines for the therapy of T2D have been introduced with the new grou...

(This article belongs to the Section Endocrinology & Metabolism)
  • Article
  • Open Access
631 Views
14 Pages

Prioritizing Antidiabetic Drugs for Inflammatory Bowel Disease Through Inverse Signal Detection: A FAERS Pharmacovigilance Study

  • Katarina Đogatović,
  • Katarina Vučićević,
  • Srđan Marković,
  • Milena Kovačević and ,
  • Milica Ćulafić,
  • Branislava Miljković and
  • Sandra Vezmar Kovačević
  • + 2 authors+ 0 author

16 June 2026

Background/Objectives: Inflammatory bowel disease (IBD) represents a growing therapeutic challenge, and the identification of novel treatment strategies remains an unmet clinical need. Drug repurposing offers a pragmatic and cost-effective alternativ...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
13 Citations
4,696 Views
14 Pages

Impact of Contextual-Level Social Determinants of Health on Newer Antidiabetic Drug Adoption in Patients with Type 2 Diabetes

  • Yujia Li,
  • Hui Hu,
  • Yi Zheng,
  • William Troy Donahoo and ,
  • Yi Guo,
  • Jie Xu,
  • Wei-Han Chen,
  • Ning Liu,
  • Elisabeth A. Shenkman and
  • Jingchuan Guo
  • + 6 authors+ 1 author

Background: We aimed to investigate the association between contextual-level social determinants of health (SDoH) and the use of novel antidiabetic drugs (ADD), including sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1...

  • Communication
  • Open Access
56 Citations
7,481 Views
12 Pages

Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis

  • Maria Mirabelli,
  • Eusebio Chiefari,
  • Luigi Puccio,
  • Daniela Patrizia Foti and
  • Antonio Brunetti

Patients with diabetes have been reported to have enhanced susceptibility to severe or fatal COVID-19 infections, including a high risk of being admitted to intensive care units with respiratory failure and septic complications. Given the global prev...

(This article belongs to the Section Environmental Health)
  • Article
  • Open Access
3 Citations
3,385 Views
23 Pages

Antidiabetic Drugs Can Reduce the Harmful Impact of Chronic Smoking on Post-Traumatic Brain Injuries

  • Farzane Sivandzade,
  • Faleh Alqahtani,
  • Hemangini Dhaibar,
  • Diana Cruz-Topete and
  • Luca Cucullo

Traumatic Brain Injury (TBI) is a primary cause of cerebrovascular and neurological disorders worldwide. The current scientific researchers believe that premorbid conditions such as tobacco smoking (TS) can exacerbate post-TBI brain injury and negati...

(This article belongs to the Special Issue Oxidative Stress and Brain Injury 3.0)
  • Review
  • Open Access
14 Citations
8,087 Views
25 Pages

The drug metabolism and drug degradation pathways may overlap, resulting in the formation of similar constituents. Therefore, the metabolism data can be helpful for deriving safe levels of degradation impurities and improving the quality of respectiv...

(This article belongs to the Section Drug Discovery, Development and Delivery)
  • Systematic Review
  • Open Access
1 Citations
3,948 Views
21 Pages

Efficacy and Safety of Non-Insulin Antidiabetic Drugs in Cats: A Systematic Review

  • Félix Romero-Vélez,
  • Juan Rejas and
  • Rafael Ruiz de Gopegui

31 August 2025

Background: While insulin is the standard of care for feline diabetes mellitus (FDM), non-insulin antidiabetic drugs (NIADs) are emerging as alternatives. This systematic review aims to synthesize and critically appraise the current evidence for the...

(This article belongs to the Section Companion Animals)
  • Review
  • Open Access
5 Citations
4,486 Views
29 Pages

This paper is part II of the review on metabolism and chemical degradation of new antidiabetic drugs from glutides, gliflozins and gliptins. It is well known that metabolism data can be helpful for deriving safe levels of degradation impurities and t...

(This article belongs to the Section Drug Discovery, Development and Delivery)
  • Article
  • Open Access
3 Citations
1,273 Views
27 Pages

Aqueous Extracts and Flavonoids Obtained from Annona cherimola Miller as Antidiabetic Treatments Alone and in Combination with Antidiabetic Drugs: In Vivo and In Silico Studies

  • Jesica Ramírez-Santos,
  • Fernando Calzada,
  • Julita Martínez-Rodríguez,
  • Miguel Valdes and ,
  • Elizabeth Barbosa and
  • Claudia Velázquez
  • + 1 author+ 0 author

18 November 2025

Background: Annona cherimola Miller (A. cherimola) is traditionally used in Mexico to treat diabetes. Objectives: this study aimed to evaluate the antihyperglycemic activity of the aqueous leaf extracts (AEAcL) and stem (AEAcS) of A. cherimola a...

(This article belongs to the Section Natural Products)
  • Article
  • Open Access
21 Citations
7,327 Views
15 Pages

17 September 2017

Diabetes mellitus (DM) poses a major health problem, for which there is an unmet need to develop novel drugs. The application of in silico techniques and optimization algorithms is instrumental to achieving this goal. A set of 97 approved anti-diabet...

  • Article
  • Open Access
536 Views
16 Pages

Structural Modifications of Hybrid O-Alkylsulfonyl-β-(Benzimidazol-1-yl)propioamidoximes as a Pathway to the Antimicrobial, Antifungal and Antidiabetic Drugs

  • Lyudmila Kayukova,
  • Anna Vologzhanina,
  • Ekaterina Dubasova,
  • Roza Seidakhmetova and ,
  • Azamat Yerlanuly,
  • Aruzhan Sartoyeva and
  • Aigul Malmakova
  • + 2 authors+ 0 author

The continuous search for new chemical structures more active and less toxic than those currently in practice is justified on the basis of the use of proven pharmacophoric building blocks (benzimidazole heterocycle, sulfonyl group and amidoxime frame...

(This article belongs to the Section Molecular Pharmacology)
  • Article
  • Open Access
12 Citations
2,645 Views
15 Pages

31 December 2024

This study represents the first-time experimental analysis of lipophilicity for antidiabetic drugs from the gliflozin class using chromatographic methods alongside computational approaches. The lipophilicity of five gliflozins (canagliflozin (CANA),...

(This article belongs to the Special Issue Analytical Insights into Bioactive Compounds in Pharmaceutical Formulations)
  • Article
  • Open Access
922 Views
22 Pages

Do We Have Enough Evidence That Metformin Is Superior to Other Antidiabetic Drugs in Pancreatic Cancer Risk Reduction?

  • Izabela Szymczak-Pajor,
  • Józef Drzewoski,
  • Sylwia Wenclewska,
  • Aneta Rogalska and
  • Agnieszka Śliwińska

The current literature indicates that type 2 diabetes (T2DM) significantly increases the risk of cancer, including pancreatic cancer (PC). While metformin’s primary role is the management of T2DM, its utility extends to systemic anti-cancer eff...

(This article belongs to the Special Issue Molecular Mechanisms and Therapies of Pancreatic Cancer: 3rd Edition)
  • Feature Paper
  • Review
  • Open Access
34 Citations
6,218 Views
34 Pages

9 August 2021

Diabetes mellitus (DM) represents a group of metabolic disorders that leads to acute and long-term serious complications and is considered a worldwide sanitary emergence. Type 2 diabetes (T2D) represents about 90% of all cases of diabetes, and even i...

(This article belongs to the Special Issue Designed Multiple Ligands in Drug Design and Development)
  • Article
  • Open Access
2 Citations
2,218 Views
13 Pages

Assessing Therapeutic Choices and Adherence to Antidiabetic Therapy in Naïve Patients: A Retrospective Observational Study in a Local Health Authority of the Piedmont Region (Italy)

  • Lucrezia Greta Armando,
  • Gianluca Miglio,
  • Raffaella Baroetto Parisi,
  • Mariangela Esiliato and ,
  • Cristina Rolando,
  • Valeria Vinciguerra,
  • Abdoulaye Diarassouba and
  • Clara Cena
  • + 3 authors+ 0 author

Due to its prevalence and socio-economic burden on health systems, diabetes mellitus (DM) is considered a major health emergency. This retrospective, observational study aimed to describe a population of DM-naïve patients of the Local Health Aut...

  • Systematic Review
  • Open Access
13 Citations
4,547 Views
14 Pages

Effect of Oral Antidiabetic Drugs on Tuberculosis Risk and Treatment Outcomes: Systematic Review and Meta-Analysis

  • Edinson Dante Meregildo-Rodriguez,
  • Martha Genara Asmat-Rubio,
  • Petterson Zavaleta-Alaya and
  • Gustavo Adolfo Vásquez-Tirado

Tuberculosis and diabetes mellitus are two global pandemics and rising public health problems. Recent studies suggest that oral antidiabetic drugs (OADs) could reduce the risk of tuberculosis and improve clinical outcomes. However, the evidence is co...

(This article belongs to the Special Issue Ending Tuberculosis Epidemic: Current Status and Future Prospects)
  • Review
  • Open Access
25 Citations
7,904 Views
34 Pages

GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer’s Disease Therapy

  • Magdalena Złotek,
  • Antonina Kurowska,
  • Mariola Herbet and
  • Iwona Piątkowska-Chmiel

12 November 2023

Alzheimer’s is a prevalent, progressive neurodegenerative disease marked by cognitive decline and memory loss. The disease’s development involves various pathomechanisms, including amyloid-beta accumulation, neurofibrillary tangles, oxida...

(This article belongs to the Special Issue State-of-the-Art Drug Discovery and Development in Poland)
  • Article
  • Open Access
4 Citations
6,017 Views
11 Pages

The Prescription and Safety of Oral Antidiabetic Drugs in Outpatients with Type 2 Diabetes Mellitus: An Observational, Retrospective, Multicenter Study on the Role of Adherence in a Real-Life Primary Care Setting

  • Gianmarco Marcianò,
  • Cristina Vocca,
  • Alessandro Casarella,
  • Luca Gallelli and ,
  • Vincenzo Rania,
  • Caterina De Sarro,
  • Rita Citraro,
  • Caterina Palleria,
  • Rosa Candida Bianco and
  • Giovambattista De Sarro
  • + 12 authors+ 7 authors

7 August 2024

Introduction: Type 2 diabetes mellitus (T2DM) is a common disease burdened with significant morbidity and mortality. Despite the substantial number of new available drug treatments, adherence to therapy and adverse drug reactions (ADRs) are the major...

  • Review
  • Open Access
45 Citations
9,334 Views
28 Pages

Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp

  • Mohamad Ali Hijazi,
  • André Gessner and
  • Nahed El-Najjar

15 June 2023

Despite the advancement in drug discovery for cancer therapy, drug repurposing remains an exceptional opportunistic strategy. This approach offers many advantages (faster, safer, and cheaper drugs) typically needed to overcome increased challenges, i...

(This article belongs to the Special Issue Drug Repurposing and Reformulation for Cancer Treatment)
  • Feature Paper
  • Review
  • Open Access
11 Citations
4,351 Views
18 Pages

Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD): Insight into Clinical Challenges in the Treatment of Type 2 Diabetes

  • Cristiana Cipriani,
  • Gabriella Lauriero,
  • Giovanni Tripepi,
  • Serge Ferrari and ,
  • Jordi Bover,
  • Maura Ravera,
  • Simona Barbuto,
  • Giuseppe Cianciolo,
  • Luca De Nicola and
  • Maria Fusaro
  • + 10 authors+ 5 authors

23 November 2023

Among the metabolic changes occurring during the course of type 2 diabetes (T2DM) and diabetic kidney disease (DKD), impaired bone health with consequent increased fracture risk is one of the most complex and multifactorial complications. In subjects...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
1 Citations
3,830 Views
18 Pages

Estimating Type 2 Diabetes Prevalence: A Model of Drug Consumption Data

  • Rita Oliveira,
  • Matilde Monteiro-Soares,
  • José Pedro Guerreiro,
  • Rúben Pereira and
  • António Teixeira-Rodrigues

22 January 2024

Observational, cross-sectional prevalence studies are costly and time-consuming. The development of indirect methods estimating prevalence used to obtain faster, less-expensive, and more robust results would be an advantage for several healthcare app...

of 27